DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Mesna

Mesna

  • Pharmacotherapy of Impaired Mucociliary Clearance in Non-CF Pediatric Lung Disease

    Pharmacotherapy of Impaired Mucociliary Clearance in Non-CF Pediatric Lung Disease

  • Supportive Care Medications

    Supportive Care Medications

  • Table III: 2019 Medicare Drug Fee Schedule* CY 2019 4Th Quarter

    Table III: 2019 Medicare Drug Fee Schedule* CY 2019 4Th Quarter

  • Mucoactive Agents for Airway Mucus Hypersecretory Diseases

    Mucoactive Agents for Airway Mucus Hypersecretory Diseases

  • Estonian Statistics on Medicines 2016 1/41

    Estonian Statistics on Medicines 2016 1/41

  • Mesna Injection

    Mesna Injection

  • Mesna: Drug Information

    Mesna: Drug Information

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • Clinical Protocol CA180372

    Clinical Protocol CA180372

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: a Scoping Review

    Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: a Scoping Review

  • The Selection and Use of Essential Medicines

    The Selection and Use of Essential Medicines

  • Injectable Medication Hcpcs/Dofr Crosswalk

    Injectable Medication Hcpcs/Dofr Crosswalk

  • Interaction of Mesna with Platinum Chemotherapy Agents Cisplatin and Carboplatin: Chemistry, in Vitro, in Vivo, and Clinical Pharmacokinetics

    Interaction of Mesna with Platinum Chemotherapy Agents Cisplatin and Carboplatin: Chemistry, in Vitro, in Vivo, and Clinical Pharmacokinetics

  • Table III 2021 Medicare National Drug Fee Schedule

    Table III 2021 Medicare National Drug Fee Schedule

  • Electronic Supplementary Material

    Electronic Supplementary Material

  • Appendix B - Product Name Sorted by Applicant

    Appendix B - Product Name Sorted by Applicant

Top View
  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
  • 2019 Table of Drugs
  • Department of Human Services IOWA Medicaid Program Draft PDL for March 9, 2006 P & T Committee Meeting PDL DRUG LIST (Two Drug Columns)
  • Medicines (Prescription Only) (Jersey) Order 1997
  • Division of Vital Statistics, Mortality Data Table Page 1 of 147
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Of Authors' Names
  • N-Acetylcysteine and Sodium 2-Mercaptoethane Sulfonate As Sources of Urinary Thiol Groups in the Rat1
  • TP Information on ANTIDOTES
  • Market Shortage Items That Are Allocated by the Manufacturer Date: 4/17/2020 *Allocation Types Are Either "W" Weekly Or "M" Monthly
  • Proposal for the Inclusion of Mesna (Sodium 2-Mercaptoethane Sulfonate)
  • Alphabetical Listing by Therapeutic Category Dod UNIFORM
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Atc Index 2010
  • CPT/HCPCS Medication Code Reference List
  • Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement
  • N-Acetylcysteine Rescue Protocol for Nephrotoxicity in Children Caused by Ifosfamide
  • Jiangsu Hengrui Medicine Co., Ltd., Established in 1970, Having Over 13,000 Employees Globally, Is the Largest Manufacturer of Antineoplastics in China


© 2024 Docslib.org    Feedback